Identifying Driver Regions in Persistent Atrial Fibrillation: A Mosaic Pattern Within the Atrial Voltage Transition Zone
Journal of Cardiovascular Electrophysiology · 2026-11 · 37 (11) · 2504-2517
DOI: 10.1111/jce.70451 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 16.07.2026. Verfasst von Naidong Pang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Heart Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Action Potentials, Pulmonary Veins. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background and Aims Driver‐targeted ablation is a potential adjunct to pulmonary vein isolation (PVI) in persistent atrial fibrillation (PsAF), yet identifying drivers remains challenging. This study investigates whether voltage characteristics can facilitate driver identification.
Methods
In a multicenter retrospective exploratory cohort of 201 patients with PsAF undergoing PVI plus driver ablation, voltage characteristics within 241 driver regions were analyzed to derive an optimal voltage transition zone. A prospective validation cohort of 53 patients subsequently underwent ablation guided by this mapping approach.
Results
The optimal voltage threshold (0.16–0.61 mV) captured 78.8% of driver regions, which frequently exhibited a mosaic pattern at the interface of low‐, transition‐, and normal‐voltage areas. This approach outperformed conventional low‐voltage area–based identification (42.3%, p = 0.004). Mosaic pattern recognition using two voltage thresholds achieved 94.2% sensitivity and 77.1% specificity. Among cases without acute AF termination, the mosaic pattern was still observed in 87.5% of driver regions. In the validation cohort, acute AF termination (69.8%) and 12‐month freedom from atrial arrhythmias were comparable to the exploratory cohort, though freedom from AF was lower ( p = 0.035) but AF proportion among recurrences was reduced ( p = 0.009). Procedure time and number of drivers ablated were also decreased ( p = 0.001 and 0.003, respectively).
Conclusion
This work proposes a hypothesis that AF driver regions in PsAF frequently exhibit a mosaic pattern under optimized voltage thresholds, which may provide a feasible adjunct to electrogram‐guided mapping; whether this approach improves clinical outcomes remains to be determined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Heart Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
- Department of Cardiology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
- Department of Cardiology, HTRM Cardiovascular Hospital, Dezhou, Shandong, China.
ORCID-Profile: Naidong Pang, Zhoubin Cao, Yirao Tao, XingPeng Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Pang, N., Cao, Z., Tao, Y., Wang, Y., Shi, L., Deng, S., Zhang, J., & Liu, X. (2026). Identifying Driver Regions in Persistent Atrial Fibrillation: A Mosaic Pattern Within the Atrial Voltage Transition Zone. Journal of Cardiovascular Electrophysiology, 37(11), 2504-2517. https://doi.org/10.1111/jce.70451
Vancouver
Pang N, Cao Z, Tao Y, Wang Y, Shi L, Deng S, et al. Identifying Driver Regions in Persistent Atrial Fibrillation: A Mosaic Pattern Within the Atrial Voltage Transition Zone. Journal of Cardiovascular Electrophysiology. 2026;37(11):2504-2517. doi:10.1111/jce.70451
BibTeX
@article{Pang2026,
author = {Pang, Naidong and Cao, Zhoubin and Tao, Yirao and Wang, Yanjiang and Shi, Liang and Deng, Simeng and Zhang, Jianjun and Liu, XingPeng},
title = {Identifying Driver Regions in Persistent Atrial Fibrillation: A Mosaic Pattern Within the Atrial Voltage Transition Zone},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
volume = {37},
number = {11},
pages = {2504--2517},
doi = {10.1111/jce.70451}
}
EUVIMED